Prescription of heroin to treatment resistant heroin addicts

doi:10.1136/bmj.328.7433.228-c

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Dutch heroin trials show retention is better with methadone alone

John Caplehorn (johnc@health.usyd.edu.au), senior lecturer

Clinical Epidemiology, School of Public Health, A27 University of Sydney, Sydney, NSW 2006, Australia

EDITOR—The conclusion by van den Brink et al that medical co-prescription of heroin to treatment resistant heroin addicts was more effective than methadone alone is not supported by all of their data.1 Rather, the better quality retention data significantly favour the methadone only group.

The trialists' claim that heroin co-prescription is superior to routine methadone maintenance is based …